Literature DB >> 12873799

Amphetamine sensitization of hallucinatory-like behaviors is dependent on prefrontal cortex in nonhuman primates.

Stacy A Castner1, Patricia S Goldman-Rakic.   

Abstract

BACKGROUND: Repeated amphetamine (AMPH) exposure in nonhuman primates produces a chronic state of monoamine dysregulation and long-lasting changes in behaviors elicited by acute AMPH (including tracking, grasping "at thin air," manipulating nonapparent stimuli, and hypervigilance) in a manner that bears a marked resemblance to symptoms of both amphetamine psychosis and paranoid schizophrenia. These abnormal responses have historically been referred to as psychotomimetic or hallucinatory-like. In contrast to negative symptoms and cognitive deficits, the positive symptoms of schizophrenia including hallucinations have not traditionally been linked to prefrontal dysfunction.
METHODS: The dorsomedial (9/8B), dorsolateral (46/8A), and inferior (45/12) sectors of prefrontal cortex were lesioned, singly or in combination. Lesioned and nonlesioned control monkeys were sensitized over a 6-week period using an intermittent schedule of escalating low doses of AMPH. Behavioral responses to acute AMPH after chronic exposure were compared with preexposure responses.
RESULTS: Bilateral lesions of prefrontal cortex performed before subchronic AMPH suppressed the sensitization of hallucinatory-like behaviors but markedly enhanced locomotor sensitization compared with control animals.
CONCLUSION: These findings indicate that the primate prefrontal cortex may be a substrate for the development of the full complement of behaviors elicited by AMPH sensitization, including hallucinatory-like behaviors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12873799     DOI: 10.1016/s0006-3223(03)00292-0

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  18 in total

1.  Psychostimulant-induced plasticity of intrinsic neuronal excitability in ventral subiculum.

Authors:  Donald C Cooper; Shannon J Moore; Nathan P Staff; Nelson Spruston
Journal:  J Neurosci       Date:  2003-10-29       Impact factor: 6.167

2.  Midline thalamic reuniens lesions improve executive behaviors.

Authors:  J A Prasad; A R Abela; Y Chudasama
Journal:  Neuroscience       Date:  2016-02-09       Impact factor: 3.590

3.  Progression of cellular adaptations in medial prefrontal and orbitofrontal cortex in response to repeated amphetamine.

Authors:  Houman Homayoun; Bita Moghaddam
Journal:  J Neurosci       Date:  2006-08-02       Impact factor: 6.167

4.  Chronic, constant-rate, gastric drug infusion in nontethered rhesus macaques (Macaca mulatta).

Authors:  Karen R Strait; Jack L Orkin; Daniel C Anderson; E Chris Muly
Journal:  J Am Assoc Lab Anim Sci       Date:  2010-03       Impact factor: 1.232

5.  The discriminative effects of the kappa-opioid hallucinogen salvinorin A in nonhuman primates: dissociation from classic hallucinogen effects.

Authors:  Eduardo R Butelman; Szymon Rus; Thomas E Prisinzano; Mary Jeanne Kreek
Journal:  Psychopharmacology (Berl)       Date:  2010-01-19       Impact factor: 4.530

Review 6.  Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction.

Authors:  Patricia S Goldman-Rakic; Stacy A Castner; Torgny H Svensson; Larry J Siever; Graham V Williams
Journal:  Psychopharmacology (Berl)       Date:  2004-04-30       Impact factor: 4.530

7.  DISC1 is associated with prefrontal cortical gray matter and positive symptoms in schizophrenia.

Authors:  Philip R Szeszko; Colin A Hodgkinson; Delbert G Robinson; Pamela Derosse; Robert M Bilder; Todd Lencz; Katherine E Burdick; Barbara Napolitano; Julia D Betensky; John M Kane; David Goldman; Anil K Malhotra
Journal:  Biol Psychol       Date:  2007-11-01       Impact factor: 3.251

8.  D2 receptor regulation of synaptic burst firing in prefrontal cortical pyramidal neurons.

Authors:  Yun Wang; Patricia S Goldman-Rakic
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-29       Impact factor: 11.205

Review 9.  Animal models of working memory: insights for targeting cognitive dysfunction in schizophrenia.

Authors:  Stacy A Castner; Patricia S Goldman-Rakic; Graham V Williams
Journal:  Psychopharmacology (Berl)       Date:  2004-01-20       Impact factor: 4.530

Review 10.  From drugs to deprivation: a Bayesian framework for understanding models of psychosis.

Authors:  P R Corlett; C D Frith; P C Fletcher
Journal:  Psychopharmacology (Berl)       Date:  2009-05-28       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.